Drug firm Unichem Laboratories on Friday said it received ₹270 crore as the first tranche of payment from Sekhmet Pharmaventures Private Limited for the sale of 19.97% equity shares in Optimus Drugs Private Limited. A consortium of private equity funds, led by PAG, had announced in May that it will acquire a controlling stake in Optimus Drugs for ₹2,000 crore.